Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human ...

Hovanesian: I would have expected a more rapid uptake of these drugs. The problem was that the first drug approved, Syfovre, had some issues with very rare, but often blinding occlusive vasculitis.

For patients with center-involved diabetic macular edema (CI-DME), lamivudine improves visual acuity, according to a st ...

Hovanesian: It’s a straightforward diagnosis to make when you see the characteristic findings of areas of dropout of retinal pigment epithelium. What’s more important is what we do about it. Often, we ...

Leafy Green VegetablesThink spinach, kale, and collard greens which are rich in lutein and zeaxanthin, antioxidants that ...

EssilorLuxottica announced on Friday (30 May) that it has entered into an agreement with MidEuropa to acquire ophthalmic ...

The trial will evaluate AXPAXLI in at least 555 patients in a multi-center, double-masked, randomized (2:2:1), 3-arm study.

Papaya isn’t just great for digestion, it supports heart health, improves immunity, boosts skin, reduces inflammation, ...

Roshni Bhat, BS, presented the study on behalf of the Harvard Ophthalmology Metabolomics in Retina (HOMeR) program, which focuses on understanding the mechanisms of AMD progression. The team conducted ...

Researchers evaluated the use of ultrawide field swept-source OCT-A to evaluate retinal vasculature in patients with sickle cell retinopathy.

Speakers: Andrew Oxtoby, Chief Executive Officer & Matthew Feinsod, Chief Medical Officer Date: Thursday, June 5 th, 2025 Following the event, a replay will be hosted on Kalaris Therapeutics’ Investor ...

LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK)2.8 million injections of repackaged ...